INSIGHTS ON CLINICAL TRIAL PARTNERING

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

• Single IRB Review: Tips For Sponsors And CROs Working With Institutional Sites

  Develop an understanding of the institutional IRB’s role and explore how sponsors and CROs can address the potential impact of mandated sIRB oversight and pave the way for smoother implementation.

• Enhancing Clinical Trial Flexibility

  Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.

• Meeting Our Customers Real-World Data Needs

  Learn how Citeline generates insights from data and uses those findings to create not only dynamic dashboards but also ongoing patient recruitment programs.

• AI-Powered Strategy Is Redefining Patient Recruitment Performance

  9/9/2025

  This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

• Working With A Specialty Oncology CRO Versus A Large Generalist CRO

  10/2/2025

  Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.

• Site Engagement Doesn't Start At First Patient In

  7/15/2025

  Site engagement starts long before enrollment. Explore how well-designed investigator meetings can set the tone, build trust, and give site teams the momentum they need to deliver.

• Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling

  3/12/2026

  See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.

• Expedite Drug Development With An Integrated CDMO-CRO Model

  2/6/2026

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.